ECDC will held a scoping meeting to identify key gaps in applied preparedness research in Europe, and to identify strategies to promote interactions between research and practitioner communities. The findings of the meeting will inform ECDC activities in the coming years.
Key discussion points for this Scoping Meting include:
Declaring an emergency is a dirty work, but someone has to do it. When facing a serious threat to global public health, even if complete evidence is lacking, someone has to take the responsibility to push the red button that activates a chain of coordinated actions (such as cooperation among states and research on vaccines). Choosing to do this, the risk of giving a false alarm is unavoidable.
WHO. 2015 Dec 18. Pandemic influenza preparedness: sharing of influenza viruses and access to vaccines and other benefits - Report of the Special Session of the Pandemic Influenza. Preparedness Framework Advisory Group
During the 2009 A(H1N1) pandemic, the issue of how many deaths were associated to the emerging virus was one of the main causes of misunderstanding between authorities and the general public, which ended in a worrying lack of trust. The pandemic, initially presented as a potential serious threat, in the end was no more severe than a common seasonal flu. Unfortunately, even nowadays, it is difficult to ascertain if and how much H1N1 pandemic was different from any other seasonal flu, based on official data.
Severe pandemics due to highly‐transmissible viruses continue to threaten the world in the 21st century. In a tightly interconnected world, infectious disease outbreaks can adversely affect economic growth, trade, tourism, business and industry, and social stability as well as public and population health. Public health authorities and researchers now collect data from many sources, and analyze these data together to estimate the incidence and prevalence of different health conditions, as well as related risk factors.
Under the umbrella of Abdus Salam Research Forum (a project of Nazarat Taleem Rabwah), the International Conference on Infectious Diseases will encompass important aspects of infectious diseases with particular attention being paid to the major challenges of the region including zoonotic diseases, malaria, tuberculosis, typhoid fever and diarrhea. In addition the increasing threat of nosocomial infections will be discussed in this meeting.
Rhett Krawit is a Californian 7-year-old kid. He survived leukaemia after a fight lasted three-and-half years that left his immune system highly compromised. He wants to go to school and he has any right to do so, but he cannot do it safely. Rhett cannot be vaccinated because his immune system is still rebuilding and the presence of unvaccinated children exposes him to diseases like measles and chicken pox, which could be lethal for him. An actual risk, since in almost one fourth of Californian schools the herd immunity has been lost because of vaccine hesitancy and refusal.
The 2015 ESCAIDE conference will take place on 11-13 November 2015. It will be hosted at the Stockholm Waterfront Congress Centre, in the heart of the city. The ESCAIDE programme will offer a huge range of exciting presentations, posters, seminars and workshops on all aspects of infectious disease prevention and control.
The alarming drop of vaccine coverage in Italy reported by the Istituto superiore di sanità and the rising scepticism towards the efficacy and safety of vaccinations is not due to parents being less informed than ten years ago. On the contrary, nowadays the resolution to take mindful health choices for their own children is a stronger drive for families to gather information. A drive that does not represent a lack of attention or a weaker desire to protect their kids.
Italy is facing a serious drop in vaccine coverage, which are falling close to – and in some cases even below – the target set by the Minister of Health in the current national plan for vaccine prevention. This is a serious problem for public health, since, for infections transmitted from man to man (tetanus being an exception), a high coverage is necessary to protect those people that cannot be vaccinated either because of their age or because of clinical reasons, such as for cancer therapies, through the mechanism of herd immunity.
